We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
4 hedge funds and large institutions have $7.5M invested in Plus Therapeutics in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% less funds holding
Funds holding: 5 → 4 (-1)
33% less capital invested
Capital invested by funds: $11.1M → $7.5M (-$3.62M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$76K
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
GCM
Goldman Capital Management
New York
|
-$1.36M |
| 2 |
Renaissance Technologies
New York
|
-$321K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$45K |
| 4 |
GS
Gagnon Securities
New York
|
-$38K |
| 5 |
AC
Amici Capital
New York
|
-$27K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
Renaissance Technologies
New York
| – | -$321K | – | – |
|
77
SG Americas Securities
New York
| – | -$9K | – | – |
|
|
TRCT
78
Tower Research Capital (TRC)
New York
| – | -$25K | – | – |
|
|
79
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$45K | – | – |
|